Physician
Livingston Pediatric Clinic PA
Livingston Pediatric Clinic PA was paid $7.41M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoLIVINGSTON PEDIATRIC CLINIC PA
LIVINGSTON, TX 77351
LIVINGSTON, TX 77351
33aNPI1891848297assigned 01/19/2007
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$7.41M
24GClaims319,898
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Texas
Rank by total paid#2 of 21
Median peer was paid$446K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 360 | $5K | |
| 2019 | 927 | $26K | |
| 2020 | 21,300 | $493K | |
| 2021 | 69,221 | $1.65M | |
| 2022 | 80,396 | $1.83M | |
| 2023 | 82,687 | $1.84M | |
| 2024incomplete | 65,007 | $1.58M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 29,132 | 25,951 | $1.56M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 38,875 | 34,343 | $1.47M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 10% | 8,469 | 8,405 | $751K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.6% | 8,545 | 8,488 | $709K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8.3% | 6,366 | 6,319 | $614K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.3% | 6,677 | 6,435 | $542K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.4% | 40,485 | 16,936 | $473K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 11,796 | 11,324 | $172K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 7,966 | 3,856 | $116K |
| 87428 | 1.5% | 1,332 | 1,303 | $108K | |
| 99381 | 1.2% | 1,068 | 1,051 | $90K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 9,892 | 7,165 | $83K |
70 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 826 | $71K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,493 | $68K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 659 | $61K |
| 99383 | <1% | 534 | $51K | |
| 90461 | <1% | 10,367 | $45K | |
| 80061 | Lipid panel | <1% | 2,929 | $32K |
| 99429 | <1% | 786 | $29K | |
| 99382 | <1% | 296 | $28K | |
| 97169 | <1% | 1,037 | $28K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,055 | $27K |
| 83655 | <1% | 2,427 | $27K | |
| 92551 | <1% | 15,428 | $27K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 163 | $24K |
| 87807 | <1% | 1,890 | $21K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 323 | $20K |
| 99384 | <1% | 193 | $20K | |
| 99000 | <1% | 1,693 | $18K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,443 | $17K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,183 | $14K |
| 99460 | <1% | 138 | $11K | |
| 82947 | <1% | 2,867 | $10K | |
| 96160 | <1% | 5,941 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 545 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 203 | $7K |
| 99462 | <1% | 148 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 508 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 59 | $5K |
| 90620 | <1% | 1,407 | $4K | |
| 85018 | <1% | 3,569 | $3K | |
| 81003 | <1% | 1,725 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 35 | $3K |
| 96161 | <1% | 983 | $3K | |
| 87631 | <1% | 14 | $2K | |
| 81025 | <1% | 233 | $2K | |
| 96380 | <1% | 84 | $2K | |
| 90651 | <1% | 2,396 | $1K | |
| 97802 | <1% | 17,948 | $497.29 | |
| 86308 | <1% | 105 | $484.81 | |
| 90686 | <1% | 4,299 | $393.85 | |
| 90734 | <1% | 1,134 | $360.57 | |
| 92587 | <1% | 18 | $245.66 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 294 | $230.89 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 19 | $218.54 |
| S8301 | Infection control supplies, not otherwise specified | <1% | 17 | $176.00 |
| 90619 | <1% | 1,287 | $159.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 93 | $146.77 |
| CP002 | <1% | 14 | $137.20 | |
| 90715 | <1% | 1,360 | $78.96 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 529 | $22.14 |
| 90671 | <1% | 441 | $0.27 | |
| 90677 | <1% | 1,162 | $0.03 | |
| 90670 | <1% | 4,057 | $0.01 | |
| 90707 | 0% | 2,827 | $0.00 | |
| 99173 | 0% | 11,264 | $0.00 | |
| 90633 | 0% | 2,997 | $0.00 | |
| 90700 | 0% | 1,316 | $0.00 | |
| 90710 | 0% | 12 | $0.00 | |
| 90672 | 0% | 61 | $0.00 | |
| 90380 | 0% | 24 | $0.00 | |
| 96127 | 0% | 397 | $0.00 | |
| 90716 | 0% | 2,815 | $0.00 | |
| 90647 | 0% | 2,742 | $0.00 | |
| 90660 | 0% | 40 | $0.00 | |
| 90697 | 0% | 2,145 | $0.00 | |
| 90696 | 0% | 1,357 | $0.00 | |
| 90680 | 0% | 3,689 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 16,503 | $0.00 |
| 90656 | 0% | 581 | $0.00 | |
| 90723 | 0% | 2,085 | $0.00 | |
| 90381 | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRAWNER, MARLO (MEDICAL DIRECTOR)